生物制剂-话题@MedSci

#生物制剂#

123篇内容 | 5572人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1826001, encodeId=62b71826001f1, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Clin Gastroenterology H：生物制剂联合免疫抑制剂治疗炎症性肠病患者可以降低相关并发症的风险, objectType=article, longId=176790, objectId=df3a1e6790b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df3a1e6790b3, replyNumber=0, likeNumber=68, createdTime=2019-09-17, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df3a1e6790b3, moduleTitle=Clin Gastroenterology H：生物制剂联合免疫抑制剂治疗炎症性肠病患者可以降低相关并发症的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df3a1e6790b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826006, encodeId=c3d3182600661, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Ann Rheum Dis：风湿病生物制剂使用者中的结核, objectType=article, longId=184170, objectId=a1251841e0ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1251841e0ec, replyNumber=0, likeNumber=64, createdTime=2020-04-29, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1251841e0ec, moduleTitle=Ann Rheum Dis：风湿病生物制剂使用者中的结核, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1251841e0ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826002, encodeId=6e97182600285, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=全球特应性皮炎靶向生物制剂Dupixent® 亮相进博会, objectType=article, longId=182540, objectId=b84d182540dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b84d182540dd, replyNumber=0, likeNumber=102, createdTime=2020-05-04, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b84d182540dd, moduleTitle=全球特应性皮炎靶向生物制剂Dupixent® 亮相进博会, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b84d182540dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826003, encodeId=e1eb182600301, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=全球特应性皮炎靶向生物制剂Dupixent® 亮相进博会, objectType=article, longId=182567, objectId=ec7418256ef8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec7418256ef8, replyNumber=0, likeNumber=73, createdTime=2020-05-25, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec7418256ef8, moduleTitle=全球特应性皮炎靶向生物制剂Dupixent® 亮相进博会, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec7418256ef8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826000, encodeId=e961182600092, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=西安杨森宣布国内每三月皮下注射一次治疗银屑病生物制剂喜达诺®上市, objectType=article, longId=167787, objectId=f96e16e787c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f96e16e787c7, replyNumber=0, likeNumber=118, createdTime=2020-01-23, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f96e16e787c7, moduleTitle=西安杨森宣布国内每三月皮下注射一次治疗银屑病生物制剂喜达诺®上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f96e16e787c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825993, encodeId=b55e182599382, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=西安杨森旗下类克为中国溃疡性结肠炎提供生物制剂新选择, objectType=article, longId=160429, objectId=fcac16042929, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcac16042929, replyNumber=0, likeNumber=114, createdTime=2019-02-25, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcac16042929, moduleTitle=西安杨森旗下类克为中国溃疡性结肠炎提供生物制剂新选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcac16042929)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825995, encodeId=70f11825995d3, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=2019 CDA实践指南：生物制剂治疗银屑病, objectType=article, longId=161738, objectId=5761161e38b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5761161e38b7, replyNumber=0, likeNumber=38, createdTime=2019-08-10, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5761161e38b7, moduleTitle=2019 CDA实践指南：生物制剂治疗银屑病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5761161e38b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825999, encodeId=e3bd1825999da, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Dig Liver Dis：生物制剂使用时小肠克罗恩病狭窄成形术后早期复发的影响因素, objectType=article, longId=166563, objectId=18811665633f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18811665633f, replyNumber=0, likeNumber=78, createdTime=2019-09-30, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18811665633f, moduleTitle=Dig Liver Dis：生物制剂使用时小肠克罗恩病狭窄成形术后早期复发的影响因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18811665633f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825994, encodeId=6bb91825994f1, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=2019 AAD/NPF指南：应用生物制剂治疗银屑病, objectType=article, longId=161044, objectId=e8ab16104440, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8ab16104440, replyNumber=0, likeNumber=38, createdTime=2019-08-21, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8ab16104440, moduleTitle=2019 AAD/NPF指南：应用生物制剂治疗银屑病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8ab16104440)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825998, encodeId=ebc31825998e8, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Semin Arthritis Rheu：老年类风湿性关节炎患者使用生物制剂的疗效和安全性, objectType=article, longId=164931, objectId=89191649313a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89191649313a, replyNumber=0, likeNumber=79, createdTime=2019-07-28, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89191649313a, moduleTitle=Semin Arthritis Rheu：老年类风湿性关节炎患者使用生物制剂的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89191649313a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825991, encodeId=9aab182599116, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=三个原则，帮你判断该不该用生物制剂, objectType=article, longId=152460, objectId=3b9615246089, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b9615246089, replyNumber=0, likeNumber=73, createdTime=2018-11-05, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b9615246089, moduleTitle=三个原则，帮你判断该不该用生物制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b9615246089)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825997, encodeId=ec78182599ee4, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Semin Arthritis Rheu：与类风湿性关节炎患者使用托珠单抗vs其他生物制剂相关的恶性肿瘤风险, objectType=article, longId=162333, objectId=0fa216233337, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fa216233337, replyNumber=0, likeNumber=76, createdTime=2019-08-09, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fa216233337, moduleTitle=Semin Arthritis Rheu：与类风湿性关节炎患者使用托珠单抗vs其他生物制剂相关的恶性肿瘤风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0fa216233337)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825996, encodeId=ca13182599672, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=J Rheumatol：使用生物制剂治疗银屑病关节炎的指炎和附着点炎, objectType=article, longId=161850, objectId=40901618500d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40901618500d, replyNumber=0, likeNumber=76, createdTime=2020-02-11, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40901618500d, moduleTitle=J Rheumatol：使用生物制剂治疗银屑病关节炎的指炎和附着点炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40901618500d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825989, encodeId=90c718259897e, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=生物制剂治疗系统性红斑狼疮面面观, objectType=article, longId=146561, objectId=461e14656184, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=461e14656184, replyNumber=0, likeNumber=77, createdTime=2019-07-26, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=461e14656184, moduleTitle=生物制剂治疗系统性红斑狼疮面面观, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=461e14656184)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825992, encodeId=08e21825992c1, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=2019 奥地利共识：孕期和哺乳期免疫抑制剂和生物制剂的应用, objectType=article, longId=158615, objectId=da1d158615be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da1d158615be, replyNumber=0, likeNumber=39, createdTime=2019-06-21, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da1d158615be, moduleTitle=2019 奥地利共识：孕期和哺乳期免疫抑制剂和生物制剂的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da1d158615be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825979, encodeId=e54718259e9a1, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Ann Rheum Dis：生物制剂治疗复发性多软骨炎的疗效和安全性, objectType=article, longId=132424, objectId=a7f51324240d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7f51324240d, replyNumber=0, likeNumber=67, createdTime=2019-01-27, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7f51324240d, moduleTitle=Ann Rheum Dis：生物制剂治疗复发性多软骨炎的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7f51324240d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825982, encodeId=4fa218259825f, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Am J Gastroenterology：延长使用糖皮质激素相比于使用生物制剂对于IBD患者来说更具有生命危险。, objectType=article, longId=134454, objectId=ae4a134454e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae4a134454e4, replyNumber=0, likeNumber=76, createdTime=2019-02-17, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae4a134454e4, moduleTitle=Am J Gastroenterology：延长使用糖皮质激素相比于使用生物制剂对于IBD患者来说更具有生命危险。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae4a134454e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825983, encodeId=d7c618259839c, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=2018 NASPGHAN临床报告：确保儿童炎症性肠病非住院患者生物制剂输注质量, objectType=article, longId=136186, objectId=22c913618672, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22c913618672, replyNumber=0, likeNumber=42, createdTime=2018-09-28, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22c913618672, moduleTitle=2018 NASPGHAN临床报告：确保儿童炎症性肠病非住院患者生物制剂输注质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22c913618672)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825988, encodeId=16c9182598825, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Intern Med J：生物制剂对类风湿性关节炎治疗的真实世界研究, objectType=article, longId=146105, objectId=c9901461054e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9901461054e, replyNumber=0, likeNumber=75, createdTime=2018-12-24, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9901461054e, moduleTitle=Intern Med J：生物制剂对类风湿性关节炎治疗的真实世界研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c9901461054e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825985, encodeId=8e941825985e6, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=BMJ：很多新药和生物制剂上市后未按照FDA要求完善信息！, objectType=article, longId=142639, objectId=9c81142639bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c81142639bf, replyNumber=0, likeNumber=72, createdTime=2018-09-01, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c81142639bf, moduleTitle=BMJ：很多新药和生物制剂上市后未按照FDA要求完善信息！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c81142639bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生物制剂

2020-05-29发表于威斯康星

一叶知秋 (审核中...)

前往app查看评论内容

#生物制剂#

Clin Gastroenterology H：生物制剂联合免疫抑制剂治疗炎症性肠病患者可以降低相关并发症的风险

2019-09-17

一叶知秋 (审核中...)

前往app查看评论内容

#生物制剂#

Ann Rheum Dis：风湿病生物制剂使用者中的结核

2020-04-29

一叶知秋 (审核中...)

前往app查看评论内容

#生物制剂#

全球特应性皮炎靶向生物制剂Dupixent® 亮相进博会

2020-05-04

一叶知秋 (审核中...)

前往app查看评论内容

#生物制剂#

全球特应性皮炎靶向生物制剂Dupixent® 亮相进博会

2020-05-25

一叶知秋 (审核中...)

前往app查看评论内容

#生物制剂#

西安杨森宣布国内每三月皮下注射一次治疗银屑病生物制剂喜达诺®上市

2020-01-23

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

西安杨森旗下类克为中国溃疡性结肠炎提供生物制剂新选择

2019-02-25

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

2019 CDA实践指南：生物制剂治疗银屑病

2019-08-10

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

Dig Liver Dis：生物制剂使用时小肠克罗恩病狭窄成形术后早期复发的影响因素

2019-09-30

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

2019 AAD/NPF指南：应用生物制剂治疗银屑病

2019-08-21

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

Semin Arthritis Rheu：老年类风湿性关节炎患者使用生物制剂的疗效和安全性

2019-07-28

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

三个原则，帮你判断该不该用生物制剂

2018-11-05

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

Semin Arthritis Rheu：与类风湿性关节炎患者使用托珠单抗vs其他生物制剂相关的恶性肿瘤风险

2019-08-09

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

J Rheumatol：使用生物制剂治疗银屑病关节炎的指炎和附着点炎

2020-02-11

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

生物制剂治疗系统性红斑狼疮面面观

2019-07-26

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

2019 奥地利共识：孕期和哺乳期免疫抑制剂和生物制剂的应用

2019-06-21

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

Ann Rheum Dis：生物制剂治疗复发性多软骨炎的疗效和安全性

2019-01-27

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

Am J Gastroenterology：延长使用糖皮质激素相比于使用生物制剂对于IBD患者来说更具有生命危险。

2019-02-17

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

2018 NASPGHAN临床报告：确保儿童炎症性肠病非住院患者生物制剂输注质量

2018-09-28

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

Intern Med J：生物制剂对类风湿性关节炎治疗的真实世界研究

2018-12-24

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

BMJ：很多新药和生物制剂上市后未按照FDA要求完善信息！

2018-09-01

科室
- - 订阅+
  - 更多科室
工具
服务